ARCH Venture Partners is an American venture capital firm that primarily invests in companies in the biotechnology industry, as well as in other industries such as semiconductors and technology. The firm was initially created by the University of Chicago and the Argonne National Laboratory to commercialize their technology, and it has since become an independent firm with a focus on investing in transformative and bold ideas.

ARCH Venture Partners

Early stage venture firm focused on life science discoveries to prevent, detect and cure disease.

Alnylam Pharmaceuticals

Beam Therapeutics

Bluebird Bio

Prime Medicine

Quanterix

Resilience

Codiak Biosciences

Twist Bioscience

UNITY Biotechnology

VBI Vaccines

Verve Therapeutics

Vir Biotechnology

Gossamer Bio

Grail

Homology Medicines

Juno Therapeutics

Karuna Therapeutics

Kura Oncology

SAGE Therapeutics

Sana Biotechnology

Denali Therapeutics

EQRx

Erasca

Lyell Immunopharma

Illumina

Fate Therapeutics

Scholar Rock

COM:ARCHVENTURE

ARCH Venture Partners

locale

market

industry

website

crunchbase

linkedin

founding date

peer of

invested in

investor of

competitor of

Metrics